Ä¢¹½ÊÓƵ

MITSUBISHI CHEMICAL GROUP
MITSUBISHI CHEMICAL GROUP

AnGes filed for approval of its HGF gene therapy product Collategene® for the first time since the introduction of the conditional/time-limited authorization system for regenerative medicine products

May 31, 2023

Mitsubishi Tanabe Pharma Corporation, a member of the Ä¢¹½ÊÓƵ, has announced the following press release.

¡öMitsubishi Tanabe Pharma¡¡Press Release
AnGes filed for approval of its HGF gene therapy product Collategene® for the first time since the introduction of the conditional/time-limited authorization system for regenerative medicine products

?Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top